<DOC>
<DOCNO>
EP-0002896
</DOCNO>
<TEXT>
<DATE>
19790711
</DATE>
<IPC-CLASSIFICATIONS>
C07C-209/00 <main>C07C-87/40</main> C07C-211/00 A61P-31/00 C07C-211/25 C07C-213/00 C07C-211/48 C07C-209/52 C07C-209/44 A61K-31/135 C07C-211/19 A61K-31/13 C07C-211/52 C07C-217/00 C07C-217/82 C07C-67/00 C07C-217/58 C07C-209/48 C07C-209/50 C07C-209/08 C07C-209/40 C07C-217/84 A61P-31/12 A61P-31/16 C07C-209/16 C07C-209/62 
</IPC-CLASSIFICATIONS>
<TITLE>
antiviral tetracyclononane derivatives, processes for their manufacture and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
ici ltdgb<sep>imperial chemical industries limited<sep>imperial chemical industries plcimperial chemical house, millbanklondon sw1p 3jfgb<sep>imperial chemical industries plc<sep>
</APPLICANT>
<INVENTOR>
swallow douglas lintin<sep>swallow, douglas lintin<sep>swallow, douglas lintinwestlands 184 prestbury roadmacclesfield cheshire sk10 3bsgb<sep>swallow, douglas lintin<sep>swallow, douglas lintinwestlands 184 prestbury roadmacclesfield cheshire sk10 3bsgb<sep>
</INVENTOR>
<ABSTRACT>
the invention relates to a pharmaceutical composition  comprising a tetracyclononane derivative of the formula:    wherein r¹, r² and r³ are hydrogen atoms or alkyl radicals  and a is ch₂ch₂ or ch-r⁴ in which r⁴ is a hydrogen atom  or an alkyl, cyclohexyl, phenylalkyl or optionally-substituted  phenyl radical, or a salt thereof.  the majority of compounds  of the formula ii are novel and they are included within the  scope of the invention, as are processes for their manufacture.   typical of the compounds disclosed is 8-(1-amino-  ethyl)tetracyclo-[4,3,0,02,4,03,7]nonane.  
</ABSTRACT>
</TEXT>
</DOC>
